Figure 2From: FISH+CD34+CD38- cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcomeComparison of overall survival (A) and events-free survival (B) of AML patients according to FISH + CD34 + CD38- percentage. A FISH+CD34+CD38- percentage of over 1% was found to be significantly associated with decreased OS and EFS.Back to article page